Cushing's Disease Session Evaluation

Question Title

* 1. Please rate the overall learning objectives of this session.
At the end of the session, I am able to:

  1-Disagree 2 3-Agree 4 5-Strongly agree
Apply strategies to mitigate challenges in the investigation and diagnosis of Cushing’s disease
Compare and contrast treatment choices and medical therapies
Assess possible complications and comorbidities over time

Question Title

* 2. Please provide feedback on the speaker:
Dr. Jessica MacKenzie-Feder

  1-Disagree 2 3-Agree 4 5-Strongly agree
The speaker presented information clearly.
The presenter was engaging and knowledgeable.
The presenter managed time effectively.
The presenter was credible and non-biased.
The speaker’s slides were good quality.

Question Title

* 3. Please provide feedback on the speaker:
Dr. André Lacroix

  1-Disagree 2 3-Agree 4 5-Strongly agree
The speaker presented information clearly.
The presenter was engaging and knowledgeable.
The presenter managed time effectively.
The presenter was credible and non-biased.
The speaker’s slides were good quality.

Question Title

* 4. Please provide feedback on the speaker:
Dr. Fabienne Langlois

  1-Disagree 2 3-Agree 4 5-Strongly agree
The speaker presented information clearly.
The presenter was engaging and knowledgeable.
The presenter managed time effectively.
The presenter was credible and non-biased.
The speaker’s slides were good quality.

Question Title

* 5. Were you able to identify any CanMEDS roles other than Medical Expert in the session? Check all that apply.

Question Title

* 6. As a result of attending this talk, list 3 things you will do differently that you were not doing before.

Question Title

* 7. Please rate your overall experience of the Cushing’s Disease: Choices, Challenges and Complications session.

  1-Disagree 2 3-Agree 4 5-Strongly agree
The speakers were engaging and knowledgeable.
The content was pertinent to my practice.
There was adequate time for questions & interaction.
The slides were clear and information was presented well.
Potential conflicts of interest were divulged.
Generic names were used consistently.
I did not perceive any commercial bias.

Question Title

* 8. What elements did you like about the session?

Question Title

* 9. What elements did you dislike about the session?

Question Title

* 10. Please share other topic suggestions or learning needs for future sessions.

T